Antibiotic Exposure and Risk of Acute Kidney Injury in Individuals With Staphylococcus aureus Bacteremia
APMIS · 2026-11 · 134 (11)
DOI: 10.1111/apm.70270 ↗Abstract
ABSTRACT Staphylococcus aureus bacteremia (SAB) is associated with acute kidney injury (AKI). Recent reports have suggested that isoxazolyl penicillins are associated with AKI. To further investigate the relationship between antibiotic treatment and risk of AKI in patients with SAB, we studied a cohort of adults with methicillin‐susceptible SAB. AKI was defined using modified KDIGO criteria. Time‐dependent associations between antibiotic exposure and AKI were evaluated using landmark analyses combined with Fine–Gray competing risk models, treating death and hospital discharge as competing events. Absolute risks were estimated using the parametric g‐formula. Of the 1867 cases, 466 (25.0%) developed AKI within 14 days of blood culture. Accounting for time‐varying antibiotic exposure and competing risks, dicloxacillin, but not penicillin and cefuroxime, was associated with an increased rate of AKI at later landmarks within Days 1–5, with a higher rate observed on Day 5 (sHR: 4.84, 95% CI: 1.58–14.79). Absolute risk estimates were similar early after infection but diverged at later time points. In patients with SAB, AKI was common and occurred predominantly within the first 5 days. When accounting for time‐varying antibiotic exposure and competing risks, dicloxacillin was associated with an increased rate of AKI at later landmarks.
EUVIMED